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Dear Sir:
Pseudoxanthoma elasticum (PXE) is an inherited metabolic dis-
ease characterized by elastic fiber fragmentation and ectopic 
calcification in various tissues.1 Cerebrovascular abnormalities 
have been sporadically reported in PXE.2 The aims of this study 
are: (1) to investigate the prevalence of internal carotid artery 
hypoplasia (ICAH) in a PXE patient cohort by comparison with 
a non-PXE patient cohort; (2) to evaluate the prevalence of in-
tracranial aneurysms (IAs) or arterial malformations (AMs) in 
ICAH PXE patients; and (3) to investigate the prevalence of 
stroke in ICAH PXE versus non-ICAH PXE patients. 
We retrospectively compared 151 PXE patients from the 
French PXE cohort (National Reference Center for PXE at An-
gers University Hospital) to 402 non-PXE patients. ICAH was 
defined as diameter <3 mm as assessed by ultrasound imaging 
and confirmed by computed tomography angiography imaging. 
Stroke was defined as an acute neurological event with focal 
symptoms and signs lasting ≥24 hours consistent with focal 
cerebral ischemia and confirmed by cerebral imaging. Patients 
were deemed to have experienced a stroke once this informa-
tion was retrieved from the medical record database.
Continuous variables were described as mean±standard de-
viation, and categorical variables were expressed as numbers 
and percentages. Chi-square test was used for categorical vari-
ables. In order to take into account possible heterogeneity be-
tween PXE- and non-PXE patients at baseline, P-value adjust-
ments (Padjusted) were made using multivariate logistic regression 
analysis (MLRA) with body mass index, Framingham-Laurier 
scores, common carotid artery diameter and ankle-brachial-in-
dex as explanatory variables of ICAH, and the same variables in 
addition to internal carotid artery (ICA) diameter and mean re-
sistive index as explanatory variables of stroke. Statistical anal-
ysis was performed using SAS version 9.4 software (SAS Insti-
tute, Cary, NC, USA). A significance threshold of 0.05 was ap-
plied to all of the statistical tests.
In this study, rules of ethics were followed for all patients in 
accordance with the Declaration of Helsinki of 2008. All pa-
tients provided informed written consent and the study was 
approved by our local ethics committee (CPP Ouest II, Angers, 
France).
Thirteen PXE patients and one non-PXE patient (8.6% vs. 
0.2%, P<0.0001) presented with ICAH (Figures 1 and 2). 
MLRA indicated that ICAH was associated with PXE (odds ratio 
[OR], 7.44; 95% confidence interval [CI], 1.20 to 46.25; Padjusted 
=0.0314). IA and AM were found in 38.5% (5/13) of ICAH PXE 
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patients (Figure 2B). No statistically significant difference in 
stroke prevalence between ICAH and non-ICAH PXE patients 
was observed (23.1% vs. 7.2%, P=0.0861) confirmed by MLRA 
where stroke prevalence was not statistically significant be-
tween PXE and non-PXE patients (OR, 1.73; 95% CI, 0.50 to 
6.01; Padjusted=0.3853).
The present study shows that ICAH is common in patients 
with PXE and is frequently associated with IA but does not 
increase the risk of stroke. The typical appearance of ICAH 
encountered in our PXE patients differed from that of athero-
sclerotic lesions or medial calcification and was devoid of 
echogenic densification or any lesions or irregularities sug-
gestive of fibrodysplasia. Prevalence of ICAH (8.6%) was 
strikingly higher than that found in non-PXE patients (0.2%). 
The results we obtained from non-PXE patients are consistent 
with those documented in the general population where 
prevalence of unilateral or bilateral ICAH is reportedly below 
0.1%.3 In the general population ICAH is bilateral in 40%, 
unilateral right-sided in 40% and unilateral left-sided in 20% 
of cases.3 This distribution echoes our findings (31% of bilat-
eral, 38% of left-sided, and 31% of right-sided ICAH in 13 
PXE patients with ICAH), suggesting similar mechanisms de-
spite higher incidence in PXE patients. 
In our study, we found that the carotid canal match to the 
ICA diameter suggesting an impaired developmental process. 
Indeed, given that the carotid canals in the skull base form 
secondary to the presence of the embryonic ICA, asymmetric 
diameters of the two carotid canals imply a developmental de-
fect of the narrow internal carotid artery.4 Computed tomogra-
phy imaging of the skull base is the best means of studying the 
carotid canal and has become the main tool for diagnosing 
ICAH.4 From a pathophysiological point of view, ICAH has been 
observed in association with various conditions, such as NF2,5,6 
polycystic kidney disease7 (PKD) and Klippel-Trenaunay syn-
drome,8 but its etiology is largely unknown. Merlin and PKD 
protein mutations cause NF2 and PKD, respectively.9,10 These 
proteins are implicated in endothelial cell mechanostransduc-
tion.9,10 They contribute to vascular morphogenesis by blood-
flow sensing.9,10 
ICAH in PXE displays unique morphological characteristics 
that differ from the clinical features usually observed in other 
vascular diseases involving stenosis of the ICA. The latter is en-
countered in several acquired diseases such as arteriosclerosis,11 
large vessel vasculitis,12 fibromuscular dysplasia,13 intimal dis-
section,14 and moyamoya disease.15 ICAH may be caused by ab-
normal signaling between the extracellular matrix and vascular 
cells. Indeed elastic fibers, which are fragmented in PXE, are a 
key regulator of vascular wall development.16 Patients with in-
herited elastin defects develop segmental stenosis of the inter-
nal lumen in various vascular beds which differs from ICAH.17 
Furthermore, elastin matrix deposition in the arterial wall 
during late fetal development is essential for normal arterial 
morphogenesis.18 We cannot, however, rule out the possibility 
that abnormalities in the fibroblasts of PXE patients might be 
instrumental in the pathogenesis of ICAH.18 Nevertheless, spe-
cific ATP-binding cassette sub-family C member 6 (ABCC6) 
mutations could not be linked to ICAH-patients because no 
phenotype-genotype correlation was observed in ICAH PXE pa-
tients in this study (data not shown). Furthermore, ICAH should 
be treated as an additional phenotypic expression of PXE. In 
our study we observed 38.5% of IA and AM in ICAH PXE pa-
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Figure 1. Prevalence of internal carotid artery hypoplasia (ICAH) in one 
cohort of pseudoxanthoma elasticum (PXE) patients and another cohort of 
non-PXE patients. *P<0.0001.
Figure 2. (A) Computed tomography angiography (CTA) with 3D volume 
rendering reconstruction of unilateral left internal carotid artery hypoplasia 
(ICAH) in a female pseudoxanthoma elasticum (PXE) patient in coronal 
plane (yellow arrow). (B) Upper view of small aneurysm of anterior commu-
nicating artery (yellow arrow) with visualization of circle of Willis and base 
of skull. (C) Reconstructed CTA image of internal carotid artery in a female 
PXE patient with left ICAH (yellow arrow).
A
B C
110 http://j-stroke.org https://doi.org/10.5853/jos.2018.02705
Omarjee et al. Internal Carotid Artery Hypoplasia in PXE
tients. Hence patients with ICAH should be screened for poten-
tial IA in the circle of Willis or AM, since the incidence of an-
eurysm is 24% to 34% in these patients compared to 2% to 
4% in the general population.3
ICAH was associated with hemorrhagic stroke in 23.1% of 
cases. In non-ICAH PXE patients, 7.2% had a history of isch-
emic stroke. No significant association was found between 
ICAH and stroke. In the general population, narrowing of the 
carotid lumen diameter results mainly from atherosclerosis and 
contributes to a higher risk of recurrent ischemic stroke.19 
Furthermore, stroke prevalence of 8.6% in our cohort of PXE 
patients (including ICAH and non-ICAH) correlates with a re-
cent study20 which reports 8% of strokes in 178 PXE patients 
from a Dutch cohort. Prevalence of stroke in the general popu-
lation of a similar age approximates 3%,21 reflecting an in-
creased risk of stroke in PXE patients.
ICAH is common in PXE patients and vascular physicians 
might test for this new feature during vascular assessment. 
Furthermore, this study suggests that PXE patients might be 
screened for ICAH. In all cases where ICAH is present, patients 
might undergo cerebral imaging to identify any aneurysms.
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